Protalix Biotherapeutics Inc (PLX) — Cash Flow Reinvestment Rate
Protalix Biotherapeutics Inc (PLX) has a Cash Flow Reinvestment Rate of 0.61x as of December 2025, reinvesting $1.24 Million (capex $1.24 Million ) from operating cash flow of $2.03 Million. Explore PLX capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Protalix Biotherapeutics Inc Cash Flow Reinvestment Rate (2009–2024)
Historical reinvestment intensity for Protalix Biotherapeutics Inc across 3 annual periods. Also explore Protalix Biotherapeutics Inc total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Protalix Biotherapeutics Inc (2009–2024)
Year-by-year capital reinvestment analysis for Protalix Biotherapeutics Inc. For live market cap and broader valuation context, see PLX market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.63x | $5.50 Million | $8.67 Million | $1.28 Million | ▼ -80.5% |
| 2012 | 3.26x | $2.07 Million | $635.00K | $2.07 Million | ▲ +2236.8% |
| 2009 | 0.14x | $6.20 Million | $44.45 Million | $6.20 Million | — |